We have now closed applications for the TREAT-NMD Becker Muscular Dystrophy Masterclass as registrations have exceeded capacity. This speaks volumes about the eagerness of healthcare professionals to improve their knowledge […]
News
TREAT-NMD Attends WMS and World Orphan Drug Conferences
Last month, TREAT-NMD participated in the World Muscle Society Conference, a fantastic event focusing on neuromuscular disorders. The conference provided a platform for practical discussions with industry partners around creating […]
Continue your Professional Development with our Free E-learning Platform!
In the dynamic realm of healthcare, continual professional development (CPD) is not merely an option but an imperative. Keeping pace with the latest advancements, best practices, and innovations in your […]
Introducing the first JND Podcast: Safety and Challenges of Gene Therapy with Carsten Bonneman
A series of podcasts has been initiated to delve into publications from the Journal of Neuromuscular Diseases, featuring insightful conversations with authors and investigators. The inaugural episode introduces Dr. Carsten […]
TREAT-NMD Alliance Ltd. Introduces Updated Governance Structure
In a notable development, TREAT-NMD Alliance Ltd., a registered charity, has introduced a revised governance framework. This update also includes TREAT-NMD Service Ltd., its wholly owned business arm. The changes […]
Virtual TREAT-NMD Advisory Committee for Therapeutics meeting held online
The second virtual meeting of the year for the TREAT-NMD Advisory Committee for Therapeutics (TACT) occurred on September 29th to review a programme in Duchenne muscular dystrophy. TACT is composed […]
